Off-Label Pharmacovigilance

ISSN： 0114-5916

Source： Drug Safety, Vol.34, Iss.10, 2011-10, pp. : 795-797

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Issue Is "Off-Evidence," Not "Off-Label"

By McGivney William T.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 6, 2006-07 ,pp. : 529-530

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Off-label prescribing in a French hospital

By Cras Audrey Conscience Marie-Agnès Rajzbaum Gérald Lillo-Le Louët Agnès Lopez Nathalie Tersen Isabelle Bezie Yvonnick

Pharmacy World and Science, Vol. 29, Iss. 2, 2007-04 ,pp. : 97-100

Springer Publishing Company

Access to resources Recommend Favorite

Off-label uses of trazodone: a review

By Bossini Letizia Casolaro Ilaria Koukouna Despoina Cecchini Federica Fagiolini Andrea

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 12, 2012-08 ,pp. : 1707-1717

Informa Healthcare

Access to resources Recommend Favorite

Off-Label Prescribing in Older Patients

By Jackson Stephen H.D.

Drugs & Aging, Vol. 29, Iss. 6, 2012-06 ,pp. : 427-434

Adis International

Access to resources Recommend Favorite

Off-label prescribing "common" in Canada

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 653, 2012-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite